Molecular release from a polymeric microreservoir device: Influence of chemistry, polymer swelling, and loading on device performance

Journal of Biomedical Materials Research - Part A

Volumn 69, Issue 3, 2004, Pages 502-512

  Grayson, Amy C Richards ^a,b   Cima, Michael J ^a   Langer, Robert ^a  

^a Massachusetts Institute of Technology Cambridge   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Drug delivery; Hydrolysis; Poly(glycolic acid); Poly(lactic acid); Swelling

Indexed keywords

CONTROLLED DRUG DELIVERY; DEGRADATION; HYDROPHILICITY; MOLECULAR WEIGHT; POLYMERIC MEMBRANES; RADIOISOTOPES;

POLY(LACTIC-CO-GLYCOLIC ACID); POLYMERIC MICRORESERVOIR DEVICE;

BIOMEDICAL EQUIPMENT;

POLYGLACTIN; POLYMER;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG RELEASE; HYDROLYSIS; HYDROPHILICITY; ISOTOPE LABELING; LIPOPHILICITY; MEMBRANE; MOLECULAR WEIGHT;

EID: 2442696544     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30019     Document Type: Article

References (28)

1. Richards Grayson AC, Choi IS, Tyler BM, Wang PP, Brem H, Cima MJ, Langer R. Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater 2003;2:767-772.
2. Richards Grayson AC, Cima MJ, Langer R. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance. Submitted for publication.
3. Anderson JM, Shive MS. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28:5-24.
4. Ramchandani M, Robinson D. In vitro and in vivo release of ciprofloxacin from PLGA 50:50 implants. J. Control Release 1998;54:167-175.
5. Blanco-Príeto M-J, Besseghir K, Zerbe O, Andris D, Orsolini P, Heimgartner F, Merkle HP, Gander B. In vitro and in vivo evaluation of a somatostatin analogue released from PLGA microspheres. J. Control Release 2000;67:19-28.
6. Mallard C, Coudane J, Rault I, Vert M. The use of additives to modulate the release of a sparingly water soluble drug entrapped in PLA50 microparticles: in vivo investigation. J Microencapsul 2000;17:95-110.
7. Herrero-Vanrell R, Ramirez L, Fernandez-Carballido A, Refojo MF. Biodegradable PLGA microspheres loaded with Ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process. Pharm Res 2000;17:1323-1328.
8. Eroǧlu H, Kaş HS, Oner L, Türkoǧlu ÖF, Akalan N, Sargon MF, Özer N. The in-vitro and in-vivo characterization of PLGA: L-PLA microspheres containing dexamethasone sodium phosphate. J Microencapsul 2001;18:603-612.
9. Jeong JH, Park TG. Novel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotides. Bioconjug Chem 2001;12:917-923.
10. Hickey T, Kreutzer D, Burgess DJ, Moussy F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res 2002;61:180-187.
11. Shi G, Cai Q, Wang C, Lu N, Wang S, Bei J. Fabrication and biocompatibility of cell scaffolds of poly(L-lactic acid) and poly(L-lactic-co-glycolic acid). Polym Adv Technol 2002;13:227-232.
12. Ma PX, Langer R. Degradation, structure and properties of fibrous nonwoven poly(glycolic acid) scaffolds for tissue engineering. Mat Res Soc Symp Proc 1995;394:99-104.
13. Gao J, Niklason L, Langer R. Surface hydrolysis of poly(glycolic acid) meshes increases the seeding density of vascular smooth muscle cells. J Biomed Mater Res 1998;42:417-424.
14. Santavirta S, Kontinnen YT, Saito T, Grönblad M, Partio E, Kemppinen P, Rokkanen P. Immune response to polyglycolic acid implants. J Bone Joint Surg 1990;72-B:597-600.
15. Athanasiou KA, Niederauer GG, Agarwal CM. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 1996;17:93-102.
16. Athanasiou KA, Schmitz JP, Agarwal CM. The effects of porosity on in vitro degradation of polylactic acid-polyglycolic acid implants used in repair of articular cartilage. Tissue Eng 1998;4:53-63.
17. Anselme K, Flautre B, Hardouin P, Chanavaz M, Ustariz C, Vert M. Fate of bioresorbable poly(lactic acid) microbeads implanted in artificial bone defects for cortical bone augmentation in dog mandible. Biomaterials 1993;14:44-50.
18. Winet H, Bao JY. Comparative bone healing near eroding polylactide-polyglycolide implants of differing crystallinity in rabbit tibial bone chambers. J Biomater Sci Polym Ed 1997;8:517-532.
19. Rand RP. Osmotic stress. http://aqueous.labs.brocku.ca/osfile.html. Accessed 12 March 2004.
20. Li S, Girard A, Garreau H, Vert M. Enzymatic degradation of polylactide stereocopolymers with predominant D-lactyl contents. Polym Degrad Stab 2001;71:61-67.
21. Viswanathan NB, Patil SS, Pandit JK, Lele AK, Kulkarni MG, Mashelkar RA. Morphological changes in degrading PLGA and P(DL)LA microspheres: implications for the design of controlled release systems. J Microencapsul 2001;18:783-800.
22. Hsu TT-P, Langer R. Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer. J Biomed Mater Res 1985;19:445-460.
23. Li SM, Garreau H, Vert M. Structure-property relationships in the case of the degradation of massive aliphatic poly-(α-hydroxy acids) in aqueous media, Part 1: Poly(DL-lactic acid). J Mater Sci Mater Med 1990;1:123-130.
24. Grizzi I, Garreau H, Li S, Vert M. Hydrolytic degradation of devices based on poly(DL-lactic acid) size-dependence. Biomaterials 1995;16:305-311.
25. Okumu FW, Cleland JL, Borchardt RT. The effect of size, charge, and cyclization of model peptides on their in vitro release from DL-PLGA microspheres. J Control Release 1997;49:133-140.
26. Sandor M, Enscore D, Weston P, Mathiowitz E. Effect of protein molecular weight on release from micron-sized PLGA microspheres. J Control Release 2001;76:297-311.
27. Li S, McCarthy S. Further investigation on the hydrolytic degradation of poly (DL-lactide). Biomaterials 1999;20:35-44.
28. Fitzgerald JF, Corrigan OI. Investigation of the mechanisms governing the release of levamisole from poly-lactide-co-glycolide delivery systems. J Control Release 1996;42:125-132.